On May 2, 2026, Bio Protocol moved 80 million BIO tokens (~$5.15M) to Binance and OKX following a new staking event. BIO price surged 100% in two days, drawing significant market attention.
Binance will list 7 new spot trading pairs on April 28 at 16:00 UTC+8, covering AVNT, BIO, CHIP, KAT, XAUT, and USD1/TRY, with spot trading bot services enabled.
Bio Protocol officially launched the PEPTAI token on Base Chain, integrating an AI agent for peptide drug discovery. 20% of supply is allocated to BIO stakers. The token's market cap briefly exceeded $15 million within 5 minutes, stabilizing at $13.5 million with $2.2 million trading volume.
DeSci leverages blockchain to reshape research funding, data sharing, and collaboration. This article explains core DeSci token functions and reviews 10 promising tokens including BIO, TRAC, and RSC for investors.
BIO Protocol aims to bring decentralized science to biotech funding through BioDAOs, tokenized IP, and community governance. Here is a closer look at its model, milestones, token utility, and market relevance.
BIO Protocol is positioning itself at the intersection of crypto, biotech, and decentralized science. This article reviews its BioDAO model, BIO token utility, tokenomics, project milestones, and the broader market implications for the DeSci sector.
BIO token surged 10% with 146% volume spike to $180M. Bio Protocol's AI PeptAI designed an ADHD drug candidate in 24 hours for under $1,500, boosting decentralized science (DeSci) momentum. Key support at $0.03.
